Atorvin Drug Interactions

Avoid concomitant use of atorvastatin with, conivaptan, cyclosporine (systemic), fusidic acid (systemic), gemfibrozil, idelalisib, pazopanib, posaconazole, red rice yeast, telaprevir, tipranavir.
Atorvastatin may increase levels/effects aliskiren, aripiprazole, cimetidine, daptomycin, digoxin, diltiazem, dofetilide, filbanserin, hydrocodone, ketoconazole (systemic), lomitapide, midazolam, nimodipine, pazopanib, pimozide, repaglinide, spironolactone, trabectedin, verapamil.
The levels/effects of atorvastatin may be increased by acipimox, amiodarone, aprepitant, asunaprevir, azithromycin (systemic), bezafibrate, boceprevir, ciprofibrate, clarithromycin, cobicistat, colchicine, conivaptan, cyclosporine (systemic), CYP3A4 inhibitors (moderate/strong), cyproterone, danazol, dasatinib, diltiazem, dronedarone, elbasvir, eltrombopag, erythromycin (systemic), fenofibrate and derivatives, fluconazole, fosaprepitant, fusidic acid (systemic), gemfibrozil, grapefruit juice, idelalisib, itraconazole, ivacaftor, ketoconazole (systemic), mifepristone, netupitant, niacin, niacinamide, ombitasvir, paritaprevir, ritonavir, dasabuvir, palbociclib, P-glycoprotein/ABCB1 inhibitors, posaconazole, protease inhibitors, quinine, raltegravir, ranolazine, red yeast rice, rupatadine, simeprevir, stiripentol, telaprevir, telithromycin, teriflunomide, tipranavir, verapamil, voriconazole.
Atorvastatin may decrease levels/effects of dabigatran etexilate, lanthanum.
The levels/effects of atorvastatin may be decreased by antacid, bexarotene (systemic), bile acid sequestrants, bosentan, CYP3A4 inducers (moderate/strong), dabrafenib, deferasirox, efavirenz, etravirine, fosphenytoin, mitotane, phenytoin, rifamycin derivatives, siltuximab, St. John's wort, tocilizumab.
Atorvastatin serum concentrations may be increased by grapefruit juice; avoid concurrent intake of large quantities of grapefruit juice (>1 quart/day).